Company / SG&A Expense
Indivior SG&A Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$634.0M
FY2025
5-year range
$469.0M / $634.0M
FY2022-FY2025
Trend
+3.6%
vs FY2024
Sector context
#29 of 213
Health Care
What the data says
Indivior's sg&a expense of $634M is higher than 86% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 3 consecutive years, from $469M in FY2022 to $634M in FY2025.
Based on SEC 10-K filings.
$634M in FY2025 with a 3-year CAGR of +10.6%. Top quartile in the Health Care sector.
Increased from $565M to $634M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 213This company $634.0M Sector average $722.3M
▼
-12.2% below sector average
Key checks
Key Insights
- Indivior's sg&a expense has grown for 3 consecutive years.
- 3-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 3.6% year-over-year.
- Ranks #29 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $634.0M | +3.6% |
| FY2024 | $612.0M | +8.3% |
| FY2023 | $565.0M | +20.5% |
| FY2022 | $469.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026